DocGo (DCGO) has a market capitalization of approximately $67M, trading at $0.68 on the NASDAQ. Market cap moves with the live share price.
DocGo's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
DocGo runs a net profit margin of -62.2%, a gross margin of 29.5%, and an operating margin of -36.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
DocGo reported revenue of
DocGo does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
DocGo carries a debt-to-equity ratio of 0.22x and a current ratio of 1.79x, with a market beta of 1.02. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For DocGo (DCGO) the key facts are: market cap $67M, revenue
Get DocGo's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.